Wegovy gets EU regulator backing on lowering heart risks in obese people
The European Medicines Agency has backed Novo Nordisk’s Wegovy to expand the weight-loss drug’s application to lower heart risks and strokes in non-diabetic.
Drugs
Health
Pharma
Drugs
Health
Pharma
Biogen, Sage halt tremor trial after ‘disappointing’ oral drug results
An oral investigational drug jointly developed by Biogen Inc., and Sage Therapeutics Inc., failed to stop essential tremors in patients, forcing the companies.
Drugs
Health
Pharma
Merck’s experimental RSV injection lowers infections in infants
The US-based Merck and Co.’s investigational medicine to protect infants from respiratory syncytial virus (RSV) disease has resulted in lowering infections, according to.
Drugs
Health
Pharma
US-based Agilent Technologies to acquire Canada’s Biovectra for $925m
HQ Team July 23, 2024: Agilent Technologies Inc., will acquire Canada-based Biovectra, a contract development and manufacturing company, for $925 million, according to.
Drugs
Health
Pharma
Conduct disorder in youth stems from changes in brain structure: NIMH
Conduct disorder is a result of extensive changes in the structure of the brain and is most noticeable in the cerebral cortex, or.
Drugs
Health
Pharma
AstraZeneca acquires France’s Amolyt Pharma for $1.05 billion
British-Swedish AstraZeneca has acquired Amolyt Pharma for $1.05 billion to gain access to Lyon, France-based company’s rare disease, late-stage pipeline.
Drugs
Health
Pharma
Pharmacy benefit managers in the US wielding ‘enormous power’: FTC report
Pharmacy benefit managers, who handle about 95% of US prescriptions, are inflating drug costs and squeezing independent pharmacies, according to a report.
Drugs
Health
Pharma
Bird flu detected in a fourth person in the US, health agency CDC says
The national public health agency of the US has reported a fourth person who was infected in the country with the highly pathogenic.
Drugs
Health
Pharma
FDA rejects Daiichi, Merck, antibody-drug conjugate application
The USFDA has rejected a Biologics License Application from Daiichi Sankyo and Merck & Co., seeking accelerated approval of patritumab deruxtecan to treat.
Drugs
Health
Pharma
Novo Nordisk to set up $4.1 billion injectables facility in US’s North Carolina
Novo Nordisk, a Danish pharmaceutical multinational, will invest $4.1 billion to build a new factory in the US to make obesity and chronic.